Sumit Ray
Artemis
5 Papers
2 Citations
Sumit Ray is an academic researcher from Artemis. The author has contributed to research in topics: Medicine & Procalcitonin. The author has an hindex of 2, co-authored 5 publications.
Chat about Author
Papers
Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020.
Yash Javeri,Ganshyam Jagathkar,Subhal Dixit,Dhruva Chaudhary,Kapil Zirpe,Yatin Mehta,Deepak Govil,Rajesh C Mishra,Srinivas Samavedam,Rahul A Pandit,Raymond Dominic Savio,Anuj M Clerk,Shrikanth Srinivasan,Deven Juneja,Sumit Ray,Tapas Kumar Sahoo,Srinivas Jakkinaboina,Nandhakishore Jampala,Ravi Jain +18 more
TL;DR: This document makes recommendations about various aspects of resource preparation, infection control, prevention of mechanical complication and surveillance related to short-term central venous catheterization, out of which 40 are strong and 14 weak recommendations.
29
A Comparative Study of the Diagnostic and Prognostic Utility of Soluble Urokinase-type Plasminogen Activator Receptor and Procalcitonin in Patients with Sepsis and Systemic Inflammation Response Syndrome.
Ankita Sharma,Sumit Ray,Ramya Mamidipalli,Atul Kakar,Parul Chugh,Ridhima Jain,Manvender S Ghalaut,Sangeeta Choudhury +7 more
TL;DR: The findings suggest that both suPAR and PCT can be used as potential test tools to differentiate between SIRS and sepsis, and procalcitonin showing a significant prognostic trend to identify nonsurvivors can help the clinicians to take relevant clinical decisions.
Evaluating the efficacy and safety of the existing repurposed pharmacological agents for treating COVID-19: a meta-analysis and systematic review of clinical trials
Nang Sujali Choupoo,Saurabh Kumar Das,Rudrashish Haldar,Hillol Sarkar,Resma Tewari,Sumit Ray +5 more
TL;DR: The study showed slightly favorable results with HCQ, monoclonal antibodies, remdesivir, and CP in treating COVID-19 patients, and further research is warranted in establishing the efficacy of studied interventions.
Hemostatic Agents in Critically Ill Patients.
TL;DR: How to cite this article: Das SK, Reddy MM, Ray S. Hemostatic Agents in Critically Ill Patients: A systematic review and meta-analysis.